RecruitingNot ApplicableNCT07765745

Effect of Thymoquinone 0.2% Gel on Bone Density, Bone Width, and Socket Preservation After Tooth Extraction

Clinical and Radiographic Evaluation of the Effect of Thymoquinone 0.2% Gel on Bone Density, Bone Width, and Socket Preservation After Tooth Extraction


Sponsor

Kafrelsheikh University

Enrollment

30 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the clinical and radiographic effects of 0.2% Thymoquinone gel on bone density, bone width, and socket preservation after tooth extraction.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Gel foam, a drug called Nano-formulated 0.2% thymoquinone gel + gel foam, and others for people with bone density, bone width, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGel foam

Patients will receive gel foam only.

DRUGThymoquinone gel + gel foam

Patients will receive 0.2% thymoquinone gel + gel foam.

DRUGNano-formulated 0.2% thymoquinone gel + gel foam

Patients will receive nano-formulated 0.2% thymoquinone gel + gel foam.


Locations(1)

Kafrelsheikh University

Kafr ash Shaykh, Kafrelsheikh, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07765745


Related Trials